Trials / Completed
CompletedNCT05711108
Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
Continuous Glucose Monitoring (CGM) to Assess Hypoglycemia in Older Adults With Diabetes in Long Term Care (LTC) Facilities
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 86 (actual)
- Sponsor
- Joslin Diabetes Center · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications). This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.
Conditions
Timeline
- Start date
- 2022-01-19
- Primary completion
- 2024-11-30
- Completion
- 2024-12-31
- First posted
- 2023-02-02
- Last updated
- 2025-10-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05711108. Inclusion in this directory is not an endorsement.